News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Samaritan Pharmaceuticals, Inc. (SPHC) Awards Central Lab Services Contract For Upcoming HIV Monotherapy Trial


10/19/2005 5:12:34 PM

LAS VEGAS--(BUSINESS WIRE)--Jan. 27, 2005--Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs announced today it has selected LabConnect to provide central lab testing services for its upcoming Monotherapy trial for HIV patients.

Read at BioSpace.com


comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES